Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK13 | Q9HB14 | 10/20 | 0.53 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26922458 | 1.00 | KCNK13 (0.53) | KCNK13TLR7GABRA1GABRA5GRIN1 | |
| SCHEMBL26922137 | 0.89 | KCNK13 (0.57) | KCNK13GRIN1GRIN2B | |
| SCHEMBL29995181 | 0.89 | KCNK13 (0.57) | KCNK13GRIN1GRIN2B | |
| SCHEMBL26921451 | 0.88 | KCNK13 (0.68) | KCNK13 | |
| SCHEMBL29995468 | 0.88 | KCNK13 (0.68) | KCNK13 | |
| SCHEMBL29995644 | 0.86 | KCNK13 (0.61) | KCNK13TLR7GABRA1GABRA5 | |
| SCHEMBL26921332 | 0.86 | KCNK13 (0.61) | KCNK13TLR7GABRA1GABRA5 | |
| SCHEMBL29995567 | 0.86 | KCNK13 (0.63) | KCNK13 | |
| SCHEMBL26922272 | 0.86 | KCNK13 (0.63) | KCNK13 | |
| SCHEMBL29995776 | 0.85 | KCNK13 (0.54) | KCNK13GABRA1GABRA5GRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4288433-A1 | NOVEL COMPOUNDS | Cerevance, Inc. (US) | 2023-12-13 | — | — | EP | claimed |
| CN-116981665-A | Novel compounds | 思瑞万斯公司 | 2023-10-31 | — | — | CN | claimed |
| WO-2022167819-A1 | NOVEL COMPOUNDS | Cerevance, Inc. (US) | 2022-08-11 | — | — | WO | claimed |
| EP-4288433-A1 | NOVEL COMPOUNDS | Cerevance, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-116981665-A | Novel compounds | 思瑞万斯公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2022167819-A1 | NOVEL COMPOUNDS | Cerevance, Inc. (US) | 2022-08-11 | — | — | WO | disclosed |